Skip to main navigation Skip to search Skip to main content

Real life experiences in HCV management in 2018

  • Mauro Viganò*
  • , Massimo Andreoni
  • , Carlo Federico Perno
  • , Antonio Craxì
  • , Alessio Aghemo
  • , Alfredo Alberti
  • , Pietro Andreone
  • , Sergio Babudieri
  • , Stefano Bonora
  • , Maurizia Rossana Brunetto
  • , Raffaele Bruno
  • , Savino Bruno
  • , Vincenza Calvaruso
  • , Nicola Caporaso
  • , Fabio Cartabellotta
  • , Francesca Ceccherini-Silberstein
  • , Valeria Cento
  • , Alessia Ciancio
  • , Piero Colombatto
  • , Nicola Coppola
  • Vito Di Marco, Giovanni Di Perri, Stefano Fagiuoli, Giovanni Battista Gaeta, Antonio Gasbarrini, Pietro Lampertico, Adriano Pellicelli, Tullio Prestileo, M Puoti, G Raimondo, Giuliano Rizzardini, Gloria Taliani, Anna Linda Zignego
*Corresponding author
  • University of Milan
  • University of Rome Tor Vergata
  • University of Palermo
  • IRCCS Istituto Clinico Humanitas - Rozzano (Milano)
  • University of Padua
  • University of Bologna
  • University of Sassari
  • University of Turin
  • University Hospital of Pisa
  • University of Pavia
  • Humanitas University
  • University of Naples Federico II
  • Ospedale Buccheri La Ferla
  • University of Campania Luigi Vanvitelli
  • ASST Papa Giovanni XXIII
  • San Camillo Hospital
  • Civico-Benfratelli Hospital
  • University of the Witwatersrand
  • University of Rome La Sapienza
  • Azienda Ospedaliera Careggi

Research output: Contribution to journalArticle

Abstract

n/a
Original languageEnglish
Pages (from-to)1-12
Number of pages12
JournalExpert Review of Anti-Infective Therapy
Issue numbern/a
DOIs
Publication statusPublished - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Microbiology
  • Microbiology (medical)
  • Infectious Diseases
  • Virology

Keywords

  • Antiviral therapy
  • DAAs
  • HCV
  • chronic liver disease
  • direct acting antivirals
  • hepatitis C virus

Fingerprint

Dive into the research topics of 'Real life experiences in HCV management in 2018'. Together they form a unique fingerprint.

Cite this